Home

Diagnosis

Alzheimer's Disease, Parkinson's Disease

Congress highlights

A pick of the mix

Though EAN 2020 was virtual, the variety and quality of its presentations was very real. These are...

Parkinson's Disease

Congress highlights

Is mild cognitive impairment in Parkinson’s disease a useful diagnosis?

The question is one of neurology’s many enduring and intriguing debates. At the AAT-AD/PD...

The neurobiology of conversion to psychosis – emerging findings from the SHARP study

The clinical high risk (CHR) phase of schizophrenia when cognitive and social functioning begin to...

Congress highlights

Early intervention for psychosis: Is it worth the investment?

In a session at WFSBP, chaired by Professor Matcheri Keshavan, Harvard Medical School, Boston, MA,...

Satellite symposium

Maintaining functioning in bipolar disorder: Treat early and prevent relapses

Bipolar disorder (BD) should be considered a neuroprogressive disorder with poor outcomes1 said...

Will the reconceptualization of negative symptoms lead to an effective therapy?

A recent reconceptualization of the negative symptoms of schizophrenia promises to increase...

Biomarkers - the Future of Diagnosis in Psychiatry?

Diagnosis of psychiatric disorders currently depends on clinical criteria. In the future the hope...

Refining and redefining diagnosis and prognosis in psychosis: can biomarkers and imaging help?

Consortia the world over are seeking biomarkers, including abnormalities on brain imaging, that...

Depression, Schizophrenia

ICD-11: new and fit for clinical utility and consistency

The new ICD chapter on mental health and behavioral disorders is designed to offer guidelines to...

Train, test, predict: Using big data and machine learning in psychiatry

Introduction of biomarkers for diagnosis and treatment of psychiatric diseases into routine...

Future of schizophrenia treatment: Where do we go now?

Over the next decade, the outcomes for patients with schizophrenia should improve considerably,...

Congress highlights

Severity and Treatment of Depression: A Review of Two Controversies

Antidepressants are not limited to severely depressed patients, and psychotherapy is not limited to...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind South East Asia Continue to Progress in Mind South Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Finland Continue to Progress in Mind Japan Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Ireland Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine

You are leaving Progress in Mind

Continue to

Cancel

You are leaving

Progress in Mind Portugal
HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in Portugal click here.

Continue to verification page Login with email

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

Accept

Decline